Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Delcath Systems (DCTH)
NASDAQ:DCTH
Holding DCTH?
Track your performance easily
Earnings Data
Report Date
Apr 01, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.02Last Year’s EPS
-$0.45Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 08, 2024
|% Change Since: 0.64%
|Next Earnings Date:Apr 01, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, successful center activations, and a robust financial position. However, challenges remain with seasonal treatment impacts and increased administrative expenses. The overall sentiment is cautiously optimistic.Company Guidance
During the Delcath Systems Q3 2024 earnings call, the company provided detailed guidance on several key metrics. They reported total revenue of $11.2 million, with $10 million from U.S. HEPZATO KIT sales and $1.2 million from European CHEMOSAT sales. The company achieved a milestone by triggering $25 million in financing through warrant exercises. They ended the quarter with 12 active treatment centers, with plans to reach 15 by year-end and 30 by the end of 2025. Average treatment rates per center were just under two treatments per month, though anticipated to dip slightly in Q4 due to holiday seasonality. The company highlighted numerous clinical studies and publications in Europe, showcasing promising results for their hepatic delivery system in various cancers. Financially, Delcath is approaching cash flow breakeven with a Q3 operating cash burn of $3.6 million, bolstered by recent warrant exercises that left them with $14 million in cash and no outstanding debt. They plan to initiate two Phase II trials for colorectal and breast cancer in 2025, aiming to leverage their strong balance sheet for further expansion and development.Strong Revenue Growth
Total revenue for Q3 2024 was $11.2 million, with $10 million from HEPZATO in the U.S. and $1.2 million from CHEMOSAT in Europe. This marks a 44% increase over Q2 2024.
Successful Center Activations
The company activated several new centers including Massachusetts General Hospital and University of California, San Diego, reaching 12 active centers with plans to increase to 30 by the end of 2025.
CHEMOSAT Revenue Increase
European revenue from CHEMOSAT increased by over 100% compared to the same period last year.
Positive Study Results
Multiple studies presented positive outcomes for HEPZATO and CHEMOSAT, including improved disease control and progression-free survival in uveal melanoma patients.
Strong Financial Position
With an operating cash burn of $3.6 million for Q3 2024 and $25 million raised from warrant exercises, the company is on the cusp of being cash flow-breakeven.
---
DCTH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DCTH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 08, 2024 | $10.94 | $11.06 | +1.10% |
| Aug 05, 2024 | $8.32 | $7.91 | -4.93% |
| May 14, 2024 | $5.40 | $7.07 | +30.93% |
| Mar 26, 2024 | $4.66 | $4.61 | -1.07% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Delcath Systems (DCTH) report earnings?
Delcath Systems (DCTH) is schdueled to report earning on Apr 01, 2025, TBA Not Confirmed.
What is Delcath Systems (DCTH) earnings time?
Delcath Systems (DCTH) earnings time is at Apr 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DCTH EPS forecast?
DCTH EPS forecast for the fiscal quarter 2024 (Q4) is -$0.02.
---